Items 61 ~ 56 of 2176, Page 7 of 272
Abbott Launches First-ever Rapid Point-of-Care HbA1c Test to Aid in the Diagnosis of Diabetes
Afinion™ HbA1c Dx test provides results in three minutes, enabling clinicians to develop informed, individualized care plans during patient consultati...
Abbott Declares 382ⁿ? Consecutive Quarterly Dividend
ABBOTT PARK, Ill., June 14, 2019 /PRNewswire/ --?The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 32 cents p...
IBM, KPMG, Merck and Walmart to collaborate as part of FDA’s program to evaluate the use of blockchain to protect pharmaceutical product integrity
The FDA pilot program explores innovative and emerging approaches for the tracing and verification of prescription products
New Survey Shows Millennials Can Help Avoid Blood Shortages
45% of blood donations have historically come from people over 50 years old, but that number is declining / As more millennials bring their passion to...
FDA Approves Two New Indications for Merck’s KEYTRUDA® (pembrolizumab)
KEYTRUDA Now Approved for First-Line Treatment of Patients with Metastatic or with Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma as Mo...
Real-World Data from Guardian(TM) Connect and Sugar.IQ(TM) Reveal Improved Diabetes Outcomes
ugar.IQ Insights Viewed as Helpful and Enable Users to Avoid Diabetes-Related Events up to Four Hours in Advance
Medtronic Announces Its Forthcoming Robotic Assisted Surgical Platform to Feature Three-Dimensional Vision System from KARL STORZ
Four Year Partnership Made Public Today
Merck to Acquire Tilos Therapeutics
Merck Gains Portfolio of Investigational Antibodies Modulating TGFβ